0
USD
U.S. (TOLL FREE)
+1 (425) 388-2538
Automative

0
U.S. (TOLL FREE)
+1 (425) 388-2538
COVID-19 Impact on Rheumatology Drugs Market, Global Research Reports 2020-2021
Published Date: May 2020
|
Report Code: QYRE-Auto-9J2874
Home | Category |Health |Pharmacy |Drugs & Medications
COVID 19 Impact on Rheumatology Drugs Market Global Research Reports 2020 2021

COVID-19 Impact on Rheumatology Drugs Market, Global Research Reports 2020-2021

Code: QYRE-Auto-9J2874
Report
May 2020
94 Pages
QYResearch
Region: Global, North America, France, Germany, Europe, Canada, South Korea, India, UK,
Description
Table of Content
Tables & Figures
This report covers market size and forecasts of Rheumatology Drugs, including the following market information:
    Global Rheumatology Drugs Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
    Global Rheumatology Drugs Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
    Global Rheumatology Drugs Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
    Global Rheumatology Drugs Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)
Key market players
Major competitors identified in this market include Takeda Pharmaceutical, Sanofi, Genentech, Novartis, Janssen Biotech, Amgen, AbbVie, Pfizer, Bristol-Myers Squibb Company, Merck & Co., etc.
Based on the Region:
    Asia-Pacific (China, Japan, South Korea, India and ASEAN)
    North America (US and Canada)
    Europe (Germany, France, UK and Italy)
    Rest of World (Latin America, Middle East & Africa)
Based on the Type:
    Disease Modifying Anti-rheumatic Drugs
    Nonsteroidal Anti-inflammatory Drugs
    Corticosteroids
    Uric Acid Drugs
    Others
Based on the Application:
    Hospital Pharmacy
    Retail Pharmacy
    Online Pharmacy
1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Rheumatology Drugs Industry
1.7 COVID-19 Impact: Rheumatology Drugs Market Trends
2 Global Rheumatology Drugs Quarterly Market Size Analysis
2.1 Rheumatology Drugs Business Impact Assessment - COVID-19
2.1.1 Global Rheumatology Drugs Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Rheumatology Drugs Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 Quarterly Competitive Assessment, 2020
3.1 By Players, Global Rheumatology Drugs Quarterly Market Size, 2019 VS 2020
3.2 By Players, Rheumatology Drugs Headquarters and Area Served
3.3 Date of Key Players Enter into Rheumatology Drugs Market
3.4 Key Players Rheumatology Drugs Product Offered
3.5 Mergers & Acquisitions, Expansion Plans
4 Impact of Covid-19 on Rheumatology Drugs Segments, By Type
4.1 Introduction
1.4.1 Disease Modifying Anti-rheumatic Drugs
1.4.2 Nonsteroidal Anti-inflammatory Drugs
1.4.3 Corticosteroids
1.4.4 Uric Acid Drugs
1.4.5 Others
4.2 By Type, Global Rheumatology Drugs Market Size, 2019-2021
5 Impact of Covid-19 on Rheumatology Drugs Segments, By Application
5.1 Overview
5.5.1 Hospital Pharmacy
5.5.2 Retail Pharmacy
5.5.3 Online Pharmacy
5.2 By Application, Global Rheumatology Drugs Market Size, 2019-2021
5.2.1 By Application, Global Rheumatology Drugs Market Size by Application, 2019-2021
6 Geographic Analysis
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 Company Profiles
7.1 Takeda Pharmaceutical
7.1.1 Takeda Pharmaceutical Business Overview
7.1.2 Takeda Pharmaceutical Rheumatology Drugs Quarterly Revenue, 2020
7.1.3 Takeda Pharmaceutical Rheumatology Drugs Product Introduction
7.1.4 Takeda Pharmaceutical Response to COVID-19 and Related Developments
7.2 Sanofi
7.2.1 Sanofi Business Overview
7.2.2 Sanofi Rheumatology Drugs Quarterly Revenue, 2020
7.2.3 Sanofi Rheumatology Drugs Product Introduction
7.2.4 Sanofi Response to COVID-19 and Related Developments
7.3 Genentech
7.3.1 Genentech Business Overview
7.3.2 Genentech Rheumatology Drugs Quarterly Revenue, 2020
7.3.3 Genentech Rheumatology Drugs Product Introduction
7.3.4 Genentech Response to COVID-19 and Related Developments
7.4 Novartis
7.4.1 Novartis Business Overview
7.4.2 Novartis Rheumatology Drugs Quarterly Revenue, 2020
7.4.3 Novartis Rheumatology Drugs Product Introduction
7.4.4 Novartis Response to COVID-19 and Related Developments
7.5 Janssen Biotech
7.5.1 Janssen Biotech Business Overview
7.5.2 Janssen Biotech Rheumatology Drugs Quarterly Revenue, 2020
7.5.3 Janssen Biotech Rheumatology Drugs Product Introduction
7.5.4 Janssen Biotech Response to COVID-19 and Related Developments
7.6 Amgen
7.6.1 Amgen Business Overview
7.6.2 Amgen Rheumatology Drugs Quarterly Revenue, 2020
7.6.3 Amgen Rheumatology Drugs Product Introduction
7.6.4 Amgen Response to COVID-19 and Related Developments
7.7 AbbVie
7.7.1 AbbVie Business Overview
7.7.2 AbbVie Rheumatology Drugs Quarterly Revenue, 2020
7.7.3 AbbVie Rheumatology Drugs Product Introduction
7.7.4 AbbVie Response to COVID-19 and Related Developments
7.8 Pfizer
7.8.1 Pfizer Business Overview
7.8.2 Pfizer Rheumatology Drugs Quarterly Revenue, 2020
7.8.3 Pfizer Rheumatology Drugs Product Introduction
7.8.4 Pfizer Response to COVID-19 and Related Developments
7.9 Bristol-Myers Squibb Company
7.9.1 Bristol-Myers Squibb Company Business Overview
7.9.2 Bristol-Myers Squibb Company Rheumatology Drugs Quarterly Revenue, 2020
7.9.3 Bristol-Myers Squibb Company Rheumatology Drugs Product Introduction
7.9.4 Bristol-Myers Squibb Company Response to COVID-19 and Related Developments
7.10 Merck & Co.
7.10.1 Merck & Co. Business Overview
7.10.2 Merck & Co. Rheumatology Drugs Quarterly Revenue, 2020
7.10.3 Merck & Co. Rheumatology Drugs Product Introduction
7.10.4 Merck & Co. Response to COVID-19 and Related Developments
8 Key Findings
9 Appendix
9.1 About US
9.2 Disclaimer
List of Tables
    Table 1. Overview of the World Economic Outlook Projections
    Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
    Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
    Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
    Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
    Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
    Table 7. Covid-19 Impact: Global Major Government Policy
    Table 8. The Covid-19 Impact on Rheumatology Drugs Assessment
    Table 9. COVID-19 Impact: Rheumatology Drugs Market Trends
    Table 10. COVID-19 Impact Global Rheumatology Drugs Market Size
    Table 11. Global Rheumatology Drugs Quarterly Market Size, 2020 (US$ Million)
    Table 12. Global Rheumatology Drugs Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
    Table 13. Global Rheumatology Drugs Market Growth Drivers
    Table 14. Global Rheumatology Drugs Market Restraints
    Table 15. Global Rheumatology Drugs Market Opportunities
    Table 16. Global Rheumatology Drugs Market Challenges
    Table 17. By Players, Rheumatology Drugs Quarterly Revenue, 2019 VS 2020 (US$ Million)
    Table 18. Key Players, Rheumatology Drugs Revenue Market Share, 2019 VS 2020 (%)
    Table 19. Key Rheumatology Drugs Players Headquarters and Area Served
    Table 20. Date of Key Players Enter into Rheumatology Drugs Market
    Table 21. Key Players Rheumatology Drugs Product Type
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. By Players, Global Rheumatology Drugs Market Size 2019-2021, (US$ Million)
    Table 24. Global Rheumatology Drugs Market Size by Application: 2019-2021 (US$ Million)
    Table 25. Global Rheumatology Drugs Market Size by Region, 2019-2021 (US$ Million)
    Table 26. By Country, North America Rheumatology Drugs Market Size, 2019-2021 (US$ Million)
    Table 27. By Type, US Rheumatology Drugs Market Size, 2019-2021 (US$ Million)
    Table 28. By Application, US Rheumatology Drugs Market Size, 2019-2021 (US$ Million)
    Table 29. By Type, Canada Rheumatology Drugs Market Size, 2019-2021 (US$ Million)
    Table 30. By Application, Canada Rheumatology Drugs Market Size, 2019-2021 (US$ Million)
    Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
    Table 32. By Country, Europe Rheumatology Drugs Market Size, 2019-2021 (US$ Million)
    Table 33. By Type, Germany Rheumatology Drugs Market Size, 2019-2021 (US$ Million)
    Table 34. By Application, Germany Rheumatology Drugs Market Size, 2019-2021 (US$ Million)
    Table 35. By Type, France Rheumatology Drugs Market Size, 2019-2021 (US$ Million)
    Table 36. By Application, France Rheumatology Drugs Market Size, 2019-2021 (US$ Million)
    Table 37. By Type, UK Rheumatology Drugs Market Size, 2019-2021 (US$ Million)
    Table 38. By Application, UK Rheumatology Drugs Market Size, 2019-2021 (US$ Million)
    Table 39. By Type, Italy Rheumatology Drugs Market Size, 2019-2021 (US$ Million)
    Table 40. By Application, Italy Rheumatology Drugs Market Size, 2019-2021 (US$ Million)
    Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
    Table 42. By Region, Asia-Pacific Rheumatology Drugs Market Size, 2019-2021 (US$ Million)
    Table 43. By Type, China Rheumatology Drugs Market Size, 2019-2021 (US$ Million)
    Table 44. By Application, China Rheumatology Drugs Market Size, 2019-2021 (US$ Million)
    Table 45. By Type, Japan Rheumatology Drugs Market Size, 2019-2021 (US$ Million)
    Table 46. By Application, Japan Rheumatology Drugs Market Size, 2019-2021 (US$ Million)
    Table 47. By Type, South Korea Rheumatology Drugs Market Size, 2019-2021 (US$ Million)
    Table 48. By Application, South Korea Rheumatology Drugs Market Size, 2019-2021 (US$ Million)
    Table 49. By Type, India Rheumatology Drugs Market Size, 2019-2021 (US$ Million)
    Table 50. By Application, India Rheumatology Drugs Market Size, 2019-2021 (US$ Million)
    Table 51. By Type, ASEAN Rheumatology Drugs Market Size, 2019-2021 (US$ Million)
    Table 52. By Application, ASEAN Rheumatology Drugs Market Size, 2019-2021 (US$ Million)
    Table 53. By Type, Latin America Rheumatology Drugs Market Size, 2019-2021 (US$ Million)
    Table 54. By Application, Latin America Rheumatology Drugs Market Size, 2019-2021 (US$ Million)
    Table 55. By Type, Middle East and Africa Rheumatology Drugs Market Size, 2019-2021 (US$ Million)
    Table 56. By Application, Middle East and Africa Rheumatology Drugs Market Size, 2019-2021 (US$ Million)
    Table 57. Takeda Pharmaceutical Business Overview
    Table 58. Takeda Pharmaceutical Rheumatology Drugs Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
    Table 59. Takeda Pharmaceutical Rheumatology Drugs Product
    Table 60. Takeda Pharmaceutical Response to COVID-19 and Related Developments
    Table 61. Sanofi Business Overview
    Table 62. Sanofi Rheumatology Drugs Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
    Table 63. Sanofi Rheumatology Drugs Product
    Table 64. Sanofi Response to COVID-19 and Related Developments
    Table 65. Genentech Business Overview
    Table 66. Genentech Rheumatology Drugs Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
    Table 67. Genentech Rheumatology Drugs Product
    Table 68. Genentech Response to COVID-19 and Related Developments
    Table 69. Novartis Business Overview
    Table 70. Novartis Rheumatology Drugs Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
    Table 71. Novartis Rheumatology Drugs Product
    Table 72. Novartis Response to COVID-19 and Related Developments
    Table 73. Janssen Biotech Business Overview
    Table 74. Janssen Biotech Rheumatology Drugs Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
    Table 75. Janssen Biotech Rheumatology Drugs Product
    Table 76. Janssen Biotech Response to COVID-19 and Related Developments
    Table 77. Amgen Business Overview
    Table 78. Amgen Rheumatology Drugs Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
    Table 79. Amgen Rheumatology Drugs Product
    Table 80. Amgen Response to COVID-19 and Related Developments
    Table 81. AbbVie Business Overview
    Table 82. AbbVie Rheumatology Drugs Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
    Table 83. AbbVie Rheumatology Drugs Product
    Table 84. AbbVie Response to COVID-19 and Related Developments
    Table 85. Pfizer Business Overview
    Table 86. Pfizer Rheumatology Drugs Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
    Table 87. Pfizer Rheumatology Drugs Product
    Table 88. Pfizer Response to COVID-19 and Related Developments
    Table 89. Bristol-Myers Squibb Company Business Overview
    Table 90. Bristol-Myers Squibb Company Rheumatology Drugs Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
    Table 91. Bristol-Myers Squibb Company Rheumatology Drugs Product
    Table 92. Bristol-Myers Squibb Company Response to COVID-19 and Related Developments
    Table 93. Merck & Co. Business Overview
    Table 94. Merck & Co. Rheumatology Drugs Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
    Table 95. Merck & Co. Rheumatology Drugs Product
    Table 96. Merck & Co. Response to COVID-19 and Related Developments
List of Figures
    Figure 1. Rheumatology Drugs Product Picture
    Figure 2. Rheumatology Drugs Market Segmentation
    Figure 3. Research Objectives
    Figure 4. Research Process
    Figure 5. Data Triangulation
    Figure 6. Research Approach
    Figure 7. Commodity Prices-Metals Price Indices
    Figure 8. Commodity Prices- Precious Metal Price Indices
    Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
    Figure 10. Commodity Prices- Food and Beverage Price Indices
    Figure 11. Commodity Prices- Fertilizer Price Indices
    Figure 12. Commodity Prices- Energy Price Indices
    Figure 13. G20+: Economic Policy Responses to COVID-19
    Figure 14. Global Rheumatology Drugs Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
    Figure 15. Global Rheumatology Drugs Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
    Figure 16. Global Rheumatology Drugs Market Size, Quarterly Growth, 2020-2021 (%)
    Figure 17. Global Rheumatology Drugs Market Size, Market Share by Type, 2019 VS 2020 (%)
    Figure 18. Global Rheumatology Drugs Market Size, Market Share by Application, 2019 VS 2020 (%)
    Figure 19. Global Rheumatology Drugs Market Size Market Share by Region, 2019 VS 2020 (%)
    Figure 20. United States Composite PMI and GDP
    Figure 21. Eurozone Composite PMI and GDP
    Figure 22. Eurozone Core v. Periphery PMI Output Indices
    Figure 23. Core v. Periphery PMI Employment Indices
    Figure 24. UK Composite PMI and GDP
    Figure 25. Caixin China Composite Output Index
    Figure 26. Caixin China General Services Business Activity Index
    Figure 27. Japan Composite Output Index
    Figure 28. South Korea Manufacturing PMI
    Figure 29. India Composite Output Index
    Figure 30. ASEAN Manufacturing PMI
    Figure 31. By Region, Asia-Pacific Rheumatology Drugs Market Size Market Share, 2019-2021
This report covers market size and forecasts of Rheumatology Drugs, including the following market information:
    Global Rheumatology Drugs Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
    Global Rheumatology Drugs Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
    Global Rheumatology Drugs Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
    Global Rheumatology Drugs Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)
Key market players
Major competitors identified in this market include Takeda Pharmaceutical, Sanofi, Genentech, Novartis, Janssen Biotech, Amgen, AbbVie, Pfizer, Bristol-Myers Squibb Company, Merck & Co., etc.
Based on the Region:
    Asia-Pacific (China, Japan, South Korea, India and ASEAN)
    North America (US and Canada)
    Europe (Germany, France, UK and Italy)
    Rest of World (Latin America, Middle East & Africa)
Based on the Type:
    Disease Modifying Anti-rheumatic Drugs
    Nonsteroidal Anti-inflammatory Drugs
    Corticosteroids
    Uric Acid Drugs
    Others
Based on the Application:
    Hospital Pharmacy
    Retail Pharmacy
    Online Pharmacy
Read More
1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Rheumatology Drugs Industry
1.7 COVID-19 Impact: Rheumatology Drugs Market Trends
2 Global Rheumatology Drugs Quarterly Market Size Analysis
2.1 Rheumatology Drugs Business Impact Assessment - COVID-19
2.1.1 Global Rheumatology Drugs Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Rheumatology Drugs Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 Quarterly Competitive Assessment, 2020
3.1 By Players, Global Rheumatology Drugs Quarterly Market Size, 2019 VS 2020
3.2 By Players, Rheumatology Drugs Headquarters and Area Served
3.3 Date of Key Players Enter into Rheumatology Drugs Market
3.4 Key Players Rheumatology Drugs Product Offered
3.5 Mergers & Acquisitions, Expansion Plans
4 Impact of Covid-19 on Rheumatology Drugs Segments, By Type
4.1 Introduction
1.4.1 Disease Modifying Anti-rheumatic Drugs
1.4.2 Nonsteroidal Anti-inflammatory Drugs
1.4.3 Corticosteroids
1.4.4 Uric Acid Drugs
1.4.5 Others
4.2 By Type, Global Rheumatology Drugs Market Size, 2019-2021
5 Impact of Covid-19 on Rheumatology Drugs Segments, By Application
5.1 Overview
5.5.1 Hospital Pharmacy
5.5.2 Retail Pharmacy
5.5.3 Online Pharmacy
5.2 By Application, Global Rheumatology Drugs Market Size, 2019-2021
5.2.1 By Application, Global Rheumatology Drugs Market Size by Application, 2019-2021
6 Geographic Analysis
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 Company Profiles
7.1 Takeda Pharmaceutical
7.1.1 Takeda Pharmaceutical Business Overview
7.1.2 Takeda Pharmaceutical Rheumatology Drugs Quarterly Revenue, 2020
7.1.3 Takeda Pharmaceutical Rheumatology Drugs Product Introduction
7.1.4 Takeda Pharmaceutical Response to COVID-19 and Related Developments
7.2 Sanofi
7.2.1 Sanofi Business Overview
7.2.2 Sanofi Rheumatology Drugs Quarterly Revenue, 2020
7.2.3 Sanofi Rheumatology Drugs Product Introduction
7.2.4 Sanofi Response to COVID-19 and Related Developments
7.3 Genentech
7.3.1 Genentech Business Overview
7.3.2 Genentech Rheumatology Drugs Quarterly Revenue, 2020
7.3.3 Genentech Rheumatology Drugs Product Introduction
7.3.4 Genentech Response to COVID-19 and Related Developments
7.4 Novartis
7.4.1 Novartis Business Overview
7.4.2 Novartis Rheumatology Drugs Quarterly Revenue, 2020
7.4.3 Novartis Rheumatology Drugs Product Introduction
7.4.4 Novartis Response to COVID-19 and Related Developments
7.5 Janssen Biotech
7.5.1 Janssen Biotech Business Overview
7.5.2 Janssen Biotech Rheumatology Drugs Quarterly Revenue, 2020
7.5.3 Janssen Biotech Rheumatology Drugs Product Introduction
7.5.4 Janssen Biotech Response to COVID-19 and Related Developments
7.6 Amgen
7.6.1 Amgen Business Overview
7.6.2 Amgen Rheumatology Drugs Quarterly Revenue, 2020
7.6.3 Amgen Rheumatology Drugs Product Introduction
7.6.4 Amgen Response to COVID-19 and Related Developments
7.7 AbbVie
7.7.1 AbbVie Business Overview
7.7.2 AbbVie Rheumatology Drugs Quarterly Revenue, 2020
7.7.3 AbbVie Rheumatology Drugs Product Introduction
7.7.4 AbbVie Response to COVID-19 and Related Developments
7.8 Pfizer
7.8.1 Pfizer Business Overview
7.8.2 Pfizer Rheumatology Drugs Quarterly Revenue, 2020
7.8.3 Pfizer Rheumatology Drugs Product Introduction
7.8.4 Pfizer Response to COVID-19 and Related Developments
7.9 Bristol-Myers Squibb Company
7.9.1 Bristol-Myers Squibb Company Business Overview
7.9.2 Bristol-Myers Squibb Company Rheumatology Drugs Quarterly Revenue, 2020
7.9.3 Bristol-Myers Squibb Company Rheumatology Drugs Product Introduction
7.9.4 Bristol-Myers Squibb Company Response to COVID-19 and Related Developments
7.10 Merck & Co.
7.10.1 Merck & Co. Business Overview
7.10.2 Merck & Co. Rheumatology Drugs Quarterly Revenue, 2020
7.10.3 Merck & Co. Rheumatology Drugs Product Introduction
7.10.4 Merck & Co. Response to COVID-19 and Related Developments
8 Key Findings
9 Appendix
9.1 About US
9.2 Disclaimer
Read More
List of Tables
    Table 1. Overview of the World Economic Outlook Projections
    Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
    Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
    Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
    Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
    Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
    Table 7. Covid-19 Impact: Global Major Government Policy
    Table 8. The Covid-19 Impact on Rheumatology Drugs Assessment
    Table 9. COVID-19 Impact: Rheumatology Drugs Market Trends
    Table 10. COVID-19 Impact Global Rheumatology Drugs Market Size
    Table 11. Global Rheumatology Drugs Quarterly Market Size, 2020 (US$ Million)
    Table 12. Global Rheumatology Drugs Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
    Table 13. Global Rheumatology Drugs Market Growth Drivers
    Table 14. Global Rheumatology Drugs Market Restraints
    Table 15. Global Rheumatology Drugs Market Opportunities
    Table 16. Global Rheumatology Drugs Market Challenges
    Table 17. By Players, Rheumatology Drugs Quarterly Revenue, 2019 VS 2020 (US$ Million)
    Table 18. Key Players, Rheumatology Drugs Revenue Market Share, 2019 VS 2020 (%)
    Table 19. Key Rheumatology Drugs Players Headquarters and Area Served
    Table 20. Date of Key Players Enter into Rheumatology Drugs Market
    Table 21. Key Players Rheumatology Drugs Product Type
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. By Players, Global Rheumatology Drugs Market Size 2019-2021, (US$ Million)
    Table 24. Global Rheumatology Drugs Market Size by Application: 2019-2021 (US$ Million)
    Table 25. Global Rheumatology Drugs Market Size by Region, 2019-2021 (US$ Million)
    Table 26. By Country, North America Rheumatology Drugs Market Size, 2019-2021 (US$ Million)
    Table 27. By Type, US Rheumatology Drugs Market Size, 2019-2021 (US$ Million)
    Table 28. By Application, US Rheumatology Drugs Market Size, 2019-2021 (US$ Million)
    Table 29. By Type, Canada Rheumatology Drugs Market Size, 2019-2021 (US$ Million)
    Table 30. By Application, Canada Rheumatology Drugs Market Size, 2019-2021 (US$ Million)
    Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
    Table 32. By Country, Europe Rheumatology Drugs Market Size, 2019-2021 (US$ Million)
    Table 33. By Type, Germany Rheumatology Drugs Market Size, 2019-2021 (US$ Million)
    Table 34. By Application, Germany Rheumatology Drugs Market Size, 2019-2021 (US$ Million)
    Table 35. By Type, France Rheumatology Drugs Market Size, 2019-2021 (US$ Million)
    Table 36. By Application, France Rheumatology Drugs Market Size, 2019-2021 (US$ Million)
    Table 37. By Type, UK Rheumatology Drugs Market Size, 2019-2021 (US$ Million)
    Table 38. By Application, UK Rheumatology Drugs Market Size, 2019-2021 (US$ Million)
    Table 39. By Type, Italy Rheumatology Drugs Market Size, 2019-2021 (US$ Million)
    Table 40. By Application, Italy Rheumatology Drugs Market Size, 2019-2021 (US$ Million)
    Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
    Table 42. By Region, Asia-Pacific Rheumatology Drugs Market Size, 2019-2021 (US$ Million)
    Table 43. By Type, China Rheumatology Drugs Market Size, 2019-2021 (US$ Million)
    Table 44. By Application, China Rheumatology Drugs Market Size, 2019-2021 (US$ Million)
    Table 45. By Type, Japan Rheumatology Drugs Market Size, 2019-2021 (US$ Million)
    Table 46. By Application, Japan Rheumatology Drugs Market Size, 2019-2021 (US$ Million)
    Table 47. By Type, South Korea Rheumatology Drugs Market Size, 2019-2021 (US$ Million)
    Table 48. By Application, South Korea Rheumatology Drugs Market Size, 2019-2021 (US$ Million)
    Table 49. By Type, India Rheumatology Drugs Market Size, 2019-2021 (US$ Million)
    Table 50. By Application, India Rheumatology Drugs Market Size, 2019-2021 (US$ Million)
    Table 51. By Type, ASEAN Rheumatology Drugs Market Size, 2019-2021 (US$ Million)
    Table 52. By Application, ASEAN Rheumatology Drugs Market Size, 2019-2021 (US$ Million)
    Table 53. By Type, Latin America Rheumatology Drugs Market Size, 2019-2021 (US$ Million)
    Table 54. By Application, Latin America Rheumatology Drugs Market Size, 2019-2021 (US$ Million)
    Table 55. By Type, Middle East and Africa Rheumatology Drugs Market Size, 2019-2021 (US$ Million)
    Table 56. By Application, Middle East and Africa Rheumatology Drugs Market Size, 2019-2021 (US$ Million)
    Table 57. Takeda Pharmaceutical Business Overview
    Table 58. Takeda Pharmaceutical Rheumatology Drugs Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
    Table 59. Takeda Pharmaceutical Rheumatology Drugs Product
    Table 60. Takeda Pharmaceutical Response to COVID-19 and Related Developments
    Table 61. Sanofi Business Overview
    Table 62. Sanofi Rheumatology Drugs Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
    Table 63. Sanofi Rheumatology Drugs Product
    Table 64. Sanofi Response to COVID-19 and Related Developments
    Table 65. Genentech Business Overview
    Table 66. Genentech Rheumatology Drugs Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
    Table 67. Genentech Rheumatology Drugs Product
    Table 68. Genentech Response to COVID-19 and Related Developments
    Table 69. Novartis Business Overview
    Table 70. Novartis Rheumatology Drugs Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
    Table 71. Novartis Rheumatology Drugs Product
    Table 72. Novartis Response to COVID-19 and Related Developments
    Table 73. Janssen Biotech Business Overview
    Table 74. Janssen Biotech Rheumatology Drugs Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
    Table 75. Janssen Biotech Rheumatology Drugs Product
    Table 76. Janssen Biotech Response to COVID-19 and Related Developments
    Table 77. Amgen Business Overview
    Table 78. Amgen Rheumatology Drugs Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
    Table 79. Amgen Rheumatology Drugs Product
    Table 80. Amgen Response to COVID-19 and Related Developments
    Table 81. AbbVie Business Overview
    Table 82. AbbVie Rheumatology Drugs Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
    Table 83. AbbVie Rheumatology Drugs Product
    Table 84. AbbVie Response to COVID-19 and Related Developments
    Table 85. Pfizer Business Overview
    Table 86. Pfizer Rheumatology Drugs Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
    Table 87. Pfizer Rheumatology Drugs Product
    Table 88. Pfizer Response to COVID-19 and Related Developments
    Table 89. Bristol-Myers Squibb Company Business Overview
    Table 90. Bristol-Myers Squibb Company Rheumatology Drugs Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
    Table 91. Bristol-Myers Squibb Company Rheumatology Drugs Product
    Table 92. Bristol-Myers Squibb Company Response to COVID-19 and Related Developments
    Table 93. Merck & Co. Business Overview
    Table 94. Merck & Co. Rheumatology Drugs Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
    Table 95. Merck & Co. Rheumatology Drugs Product
    Table 96. Merck & Co. Response to COVID-19 and Related Developments
List of Figures
    Figure 1. Rheumatology Drugs Product Picture
    Figure 2. Rheumatology Drugs Market Segmentation
    Figure 3. Research Objectives
    Figure 4. Research Process
    Figure 5. Data Triangulation
    Figure 6. Research Approach
    Figure 7. Commodity Prices-Metals Price Indices
    Figure 8. Commodity Prices- Precious Metal Price Indices
    Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
    Figure 10. Commodity Prices- Food and Beverage Price Indices
    Figure 11. Commodity Prices- Fertilizer Price Indices
    Figure 12. Commodity Prices- Energy Price Indices
    Figure 13. G20+: Economic Policy Responses to COVID-19
    Figure 14. Global Rheumatology Drugs Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
    Figure 15. Global Rheumatology Drugs Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
    Figure 16. Global Rheumatology Drugs Market Size, Quarterly Growth, 2020-2021 (%)
    Figure 17. Global Rheumatology Drugs Market Size, Market Share by Type, 2019 VS 2020 (%)
    Figure 18. Global Rheumatology Drugs Market Size, Market Share by Application, 2019 VS 2020 (%)
    Figure 19. Global Rheumatology Drugs Market Size Market Share by Region, 2019 VS 2020 (%)
    Figure 20. United States Composite PMI and GDP
    Figure 21. Eurozone Composite PMI and GDP
    Figure 22. Eurozone Core v. Periphery PMI Output Indices
    Figure 23. Core v. Periphery PMI Employment Indices
    Figure 24. UK Composite PMI and GDP
    Figure 25. Caixin China Composite Output Index
    Figure 26. Caixin China General Services Business Activity Index
    Figure 27. Japan Composite Output Index
    Figure 28. South Korea Manufacturing PMI
    Figure 29. India Composite Output Index
    Figure 30. ASEAN Manufacturing PMI
    Figure 31. By Region, Asia-Pacific Rheumatology Drugs Market Size Market Share, 2019-2021
Read More
SELECT A FORMAT
Added to Cart

Single User

Electronic (PDF)
$3250
This license allows only one user(purchaser of the report) to access the PDF.

Multi User

Electronic (PDF)
$4875
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)
$6500
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Samsung SD

RELATED REPORTS

Global Quinolone Antibiotic Market Size Status and Forecast 2020 2026
Global Quinolone Antibiotic Market Size, Status and Forecast 2020-2026

120 Pages
Type: Report
Code: QYRE-Auto-29D2970
Mon Jul 20 00:00:00 UTC 2020

Add to Cart

Global OTC Analgesics Market Size Status and Forecast 2020 2026
Global OTC Analgesics Market Size, Status and Forecast 2020-2026

120 Pages
Type: Report
Code: QYRE-Auto-27T2937
Mon Jul 20 00:00:00 UTC 2020

Add to Cart

Global Anticancer Drug Market Size Status and Forecast 2020 2026
Global Anticancer Drug Market Size, Status and Forecast 2020-2026

120 Pages
Type: Report
Code: QYRE-Auto-1S3390
Mon Jul 20 00:00:00 UTC 2020

Add to Cart

Global Fetal Alcohol Spectrum Disorder Treatment Market Size Status and Forecast 2020 2026
Global Fetal Alcohol Spectrum Disorder Treatment Market Size, Status and Forecast 2020-2026

120 Pages
Type: Report
Code: QYRE-Auto-31H2950
Mon Jul 20 00:00:00 UTC 2020

Add to Cart

0 Items
X
No items in the cart.
$0.0